The American Medical Association today adopted a policy declaring drug shortages an urgent public health crisis. As part of the policy, AMA will urge the Department of Health and Human Services and the Department of Homeland Security to examine drug shortages as a national security initiative, and call for greater manufacturer transparency regarding production location and problems and more information on the quality of outsourcing compounding facilities. The policy supports recommendations issued last year by the American Society of Healthy-System Pharmacists, AHA and other organizations as part of a drug shortages roundtable.   

Related News Articles

Headline
Hospitals spend close to $360 million each year to manage drug shortages, according to a study released this week by Vizient Inc.
Headline
The House Judiciary Committee yesterday approved by voice vote the Creating and Restoring Equal Access to Equivalent Samples Act (H.R. 965).
Headline
Civica Rx, the not-for-profit generic drug company, officially opened its headquarters last week in Lehi, Utah.
Headline
The Food and Drug Administration Friday released draft guidance on how drug developers can apply for the agency’s Competitive Generic Therapies designation.
Headline
The AHA today submitted to the Food and Drug Administration legislative, regulatory and best practice recommendations to address new and chronic prescription…
Headline
The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists, and Institute for Safe…